LifeScience Clinical & Diagnostic

Ascletis Completes Enrollment For Phase II Study Of Oral GLP 1R Agonist ASC30 In Type 2 Diabetes

- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-d...

 April 27, 2026 | News

Quasar Medical Expands Global Capacity With New Chonburi Manufacturing Facility

The new Chonburi facility increases global manufacturing capacity and strengthens regional supply chain capabilities for leading MedTech customers Quasar ...

 April 27, 2026 | News

Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML

 Regulatory Filing in Japan Planned Following Clinical Trial Completion – Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura...

 April 27, 2026 | News

AscendCare Launches Public Initiative To Normalise Preventive Health Screenings

AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe healt...

 April 24, 2026 | News

Everest Medicines Reports Promising First In Human Data For Personalised mRNA Cancer Vaccine EVM16

Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...

 April 24, 2026 | News

Dawn Medical Technologies Enters Vietnam With Pinnacle Health Acquisition

Strategic entry into high-growth Vietnam market Combines Dawn's product sourcing capabilities with Pinnacle Health's established local presence and mark...

 April 23, 2026 | News

Datasea Delivers AI Multimodal Projects Worth RMB 6.9 Million To Accelerate High Margin Shift

Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...

 April 22, 2026 | News

SynSmart And Amporin Partner To Advance Small Molecule Therapies For Degenerative Diseases

SynSmart Rasayan Research Private Limited and Amporin Pharmaceuticals AG  announced a collaboration to develop breakthrough small molecule therapeutic...

 April 22, 2026 | News

Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients

Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...

 April 21, 2026 | News

Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...

 April 17, 2026 | News

Perceptive Discovery Partners MH3D To Launch α Sight Imaging For Alpha Radiopharmaceuticals

Perceptive Discovery announced a strategic partnership with MH3D alongside the launch of α-Sight™, a new preclinical imaging offering enabling ...

 April 17, 2026 | News

Mabwell Secures NMPA IND Acceptance For First In Class LILRB4 CD3 Bispecific Antibod

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Ad...

 April 17, 2026 | News

DualityBio Secures NMPA Review For Trastuzumab Pamirtecan In HER2 Positive Breast Cancer

DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...

 April 14, 2026 | News

Haisco Partners With AbbVie To Advance Global Pain Therapeutics Pipeline

Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with AbbVie (NYSE: ABBV), a...

 April 14, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close